ArriVent BioPharma, Inc. Common Stock (AVBP)
NASDAQ·Healthcare·Biotechnology
$30.54
+0.88%
Mkt Cap $1.42B
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (7 analysts)
$44.00
Range $43.00 – $45.00
Implied Upside
+44.1%
Consensus $44.00 vs current $30.54